Naltrexone in the Treatment of Pyromania
NCT00467454 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2011-12-14
Summary
The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 10 subjects with pyromania.
Conditions
- Pyromania
Interventions
- DRUG
-
Naltrexone
daily
- DRUG
-
daily
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jon E Grant, M.D. · University of Minnesota
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- United States
Study Locations
More Related Trials
-
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients
NCT04762758 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS
NCT05214963 ·Status: COMPLETED ·Phase: NA
-
Safety Study of HPP593 in Subjects During and After Limb Immobilization
NCT01524406 ·Status: TERMINATED ·Phase: PHASE1
-
Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
NCT01472263 ·Status: COMPLETED ·Phase: PHASE3
-
SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
NCT00344994 ·Status: COMPLETED ·Phase: PHASE4
-
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
NCT01386944 ·Status: COMPLETED
-
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
NCT01521663 ·Status: COMPLETED ·Phase: PHASE2
-
Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans
NCT01898013 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
NCT04094948 ·Status: WITHDRAWN ·Phase: PHASE2
-
Open Label Study of Duloxetine for the Treatment of Phantom Limb Pain
NCT00425230 ·Status: TERMINATED ·Phase: NA
-
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
NCT00806026 ·Status: COMPLETED ·Phase: PHASE3
-
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
NCT01569464 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
NCT00225862 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans
NCT03754842 ·Status: COMPLETED ·Phase: NA
-
Bupropion and Restless Legs Syndrome
NCT00621517 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome
NCT00626418 ·Status: COMPLETED ·Phase: PHASE2
-
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
NCT01535664 ·Status: COMPLETED
-
IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
NCT00488839 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Pramipexole Extended Release in the Treatment of Essential Tremor
NCT01441284 ·Status: WITHDRAWN ·Phase: PHASE3
-
Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
NCT00197080 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
NCT05196828 ·Status: COMPLETED ·Phase: NA
-
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
NCT02720744 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
NCT00051961 ·Status: COMPLETED
-
Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia
NCT05613114 ·Status: COMPLETED ·Phase: NA
-
A Study of TAK-994 in Adults With Narcolepsy
NCT04820842 ·Status: TERMINATED ·Phase: PHASE2